Gene expression profiling studies have indicated that ALL Ph+ patients frequently carry co-occurring mutations (e.g., IKZF1, PAX5, EBF1) with BCR-ABL1 fusion. The gene discussed is BCR; the disease is acute lymphoblastic leukemia.